The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades:
UBS upgraded Thermo Fisher (TMO) to Buy from Neutral with a price target of $730, up from $540, after a transfer in analyst coverage. Thermo Fisher is positioned for a durable return to 5%-6%-plus organic growth in 2027, supported by improving pharma/biotech funding, bioprocessing demand, reshoring, AI-driven R&D investment, share gains, and stabilization in China and A&G, the firm tells investors in a research note.
BofA upgraded Figure Technology (FIGR) to Neutral from Underperform with a price target of $49, up from $31. The firm cites the company's stronger revenue growth outlook into 2028 due to Figure Connect momentum for the upgrade.
Wells Fargo upgraded Martin Marietta (MLM) to Overweight from Equal Weight with a price target of $609, up from $581. The firm cites the company's benefits to 2027 earnings from its recently closed Lhoist North America acquisition, plus pricing catch-up from the Quikrete asset swap and New Frontier acquisition for the upgrade.